Hôpital Necker-Enfants Malades

Hôpital Necker-Enfants Malades, located in the 15th arrondissement of Paris, is France's foremost pediatric hospital and one of the most respected children's medical centers in the world. Established in 1802, it is the oldest children's hospital in France and holds a storied place in the history of pediatric medicine. The hospital is part of AP-HP (Assistance Publique–Hôpitaux de Paris), Europe's largest hospital system.

Necker-Enfants Malades is both a pediatric and adult hospital, but it is primarily known for its exceptional pediatric services. The hospital serves as a national and European reference center for rare diseases, treating children with complex conditions that few other institutions in the world can address. It is home to the Imagine Institute, a world-class research facility dedicated to genetic diseases, which brings together over 900 researchers, clinicians, and engineers working to understand and treat rare genetic conditions.

France's healthcare system — ranked number one globally by the World Health Organization — provides a robust framework of clinical excellence and universal access that underpins the hospital's mission. Necker-Enfants Malades is a pioneer in pediatric organ transplantation, having performed France's first pediatric kidney transplant and remaining a leading center for pediatric liver, kidney, and heart transplants. The hospital's immunology department has made groundbreaking contributions to gene therapy research, including some of the world's first successful gene therapy treatments for severe combined immunodeficiency (SCID), commonly known as "bubble boy disease."

As a university hospital affiliated with Université Paris Cité, Necker-Enfants Malades combines clinical care with world-leading research and medical education, training the next generation of pediatric specialists and contributing to medical advances that benefit children globally.

Hôpital Necker-Enfants Malades receives families from around the world seeking care for children with rare, complex, or life-threatening conditions. Through the AP-HP international patient office, the hospital provides comprehensive support for families traveling to Paris for their child's treatment. Services include pre-arrival medical evaluation and consultation with specialists, coordination of multi-disciplinary treatment plans, assistance with travel logistics and visa documentation, and interpreter services.

The hospital's social services team is particularly experienced in supporting international families, providing guidance on accommodation near the hospital, helping families navigate the French healthcare system, and offering psychological support during extended treatment stays. Paris's excellent international connectivity via Charles de Gaulle and Orly airports ensures that families can reach Necker-Enfants Malades from virtually anywhere in the world. Costs for international patients are transparent and communicated in advance through the AP-HP international office.

Hopital Necker-Enfants Malades is the pre-eminent paediatric and rare disease center in France and one of the most important children's hospitals in the world. Its specialty portfolio reflects its unique role as both a national referral center for the most complex paediatric conditions and as a globally recognized institution for rare genetic and immunological diseases.

Paediatric surgery at Necker covers the full spectrum of childhood surgical conditions, from neonatal emergencies through to complex abdominal, thoracic, and urological reconstructive procedures. The paediatric cardiac surgery program is one of France's most active, performing surgical repair of the entire range of congenital heart defects from the simplest to the most complex single-ventricle anatomy.

Paediatric organ transplantation is one of the hospital's most internationally recognized programs. Necker performs kidney, liver, heart, and intestinal transplants in children, with patient survival outcomes among the best in the world. The transplant program draws patients from across France and internationally, including children for whom no transplant capability exists in their home country.

Rare diseases and clinical genetics constitute the most distinctive component of Necker's mission. The hospital is France's national reference center for multiple rare disease categories. Primary immunodeficiencies, genetic disorders of the immune system, is a globally leading program, pioneering gene therapy approaches that have changed treatment for conditions such as SCID (Severe Combined Immunodeficiency).

Adult services at Necker include nephrology and internal medicine, providing continuity of care for patients who initially received paediatric care at the hospital and for adults with rare diseases that overlap with the paediatric rare disease programs.

Hopital Necker-Enfants Malades occupies a modern healthcare campus in the 15th arrondissement of Paris, with the main clinical buildings reflecting major AP-HP investment in paediatric facilities. The hospital's design is oriented toward the specific needs of children and their families, with age-appropriate ward environments, family accommodation options, and child-friendly spaces throughout the clinical areas.

Paediatric wards include specialized units for cardiac surgery recovery, organ transplant patients, oncology, rare disease management, and general paediatric medicine and surgery. A Paediatric Intensive Care Unit (PICU) provides the highest level of critical care for the most severely ill children. A dedicated Neonatal Intensive Care Unit (NICU) manages premature and critically ill newborns.

Surgical facilities include specialist operating theatres for paediatric cardiac surgery, paediatric organ transplantation, complex abdominal surgery, and urological reconstruction. Cardiac surgery theatres are equipped with cardiopulmonary bypass systems and the specialized monitoring required for cardiac surgery in small children and neonates.

Diagnostic imaging facilities include paediatric-configured MRI with anesthetic support capability for children requiring sedation, CT, echocardiography including fetal echocardiography, ultrasound, and nuclear medicine. The molecular genetics and immunology laboratories provide the specialized diagnostic tests required for rare disease diagnosis and gene therapy program monitoring. A dedicated research institute on the Necker campus houses laboratories of Inserm units affiliated with the hospital's rare disease programs.

Hopital Necker-Enfants Malades holds HAS (Haute Autorite de Sante) certification, France's national hospital quality accreditation, as part of AP-HP's (Assistance Publique, Hopitaux de Paris) network-wide quality management system. AP-HP as a whole undergoes HAS certification, with Necker additionally evaluated for its specialist pediatric and rare disease functions.

As France's primary national reference center (Centre de Reference Maladies Rares) for multiple rare disease categories, Necker operates under specific Ministry of Health designation and reporting requirements for rare disease centers. This designation reflects the hospital's recognized excellence in rare disease diagnosis, treatment, and research, and is renewed through periodic government evaluation of clinical outcomes and research output.

The hospital's gene therapy programs are conducted under the regulatory oversight of ANSM (Agence Nationale de Securite du Medicament), the French medicines agency. International research collaborations, including participation in European Reference Networks (ERNs) for rare diseases, bring additional quality oversight through peer review and shared clinical guidelines.

Necker's university hospital affiliation with Universite Paris Cite adds academic quality oversight for its education and research programs. The hospital's consistently outstanding international reputation, validated by patient outcomes in cardiac surgery, organ transplantation, and rare disease treatment, remains the strongest evidence of its sustained quality.